Revolution Medicines, Inc. <RVMD.O>: Wedbush raises target price to $201 from $192.1
RVMD•Related News
Propanc Biopharma accelerates Phase 1b first-in-human PRP trial in advanced solid tumors
PPCB•
Sonoma Pharma FY27 Q1 net loss narrows 73.41% to USD 330,000; revenue rises 60% to USD 6.41 million
SNOA•
Liberty Capital Q2 revenue flat as consumer revenue decline
GLIBA•
Alibaba announces annual shareholder meeting notice
BABA•
Investors Title Q2 FY26 net income rises 18.7% to $14.6 million; revenue increases 17.5% to $86.5 million
ITIC•